NCT00104247View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels

PHASE3CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

February 28, 2006

Conditions
Phenylketonurias
Interventions
DRUG

sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterin

Trial Locations (13)

Unknown

Los Angeles

Oakland

New Haven

Chicago

Boston

Minneapolis

St Louis

New York

Portland

Pittsburgh

Dallas

Salt Lake City

Madison

Sponsors
All Listed Sponsors
lead

BioMarin Pharmaceutical

INDUSTRY